that with a positive predictive value of 94 percent, the iKnife could soon “immediately reassure” someone of an extremely low likelihood of cancer, while also expediting additional testing and treatment for those with potentially positive biopsies.
The researchers’ initial testing compared iKnife’s results with traditional diagnostic methods for 150 people’s biopsy tissue samples. Following a future major clinical trial, the iKnife’s newest capability could become yet another widespread feature for the smart device.Andrew Paul is Popular Science's staff writer covering tech news. Previously, he was a regular contributor to The A.V.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: